Biocon Ltd

NSE: BIOCON · BSE: 532523 · Pharmaceuticals & Biotechnology · 57 announcements

Biocon Ltd news stories on ALFA NewsRead the news →

Share price: ₹360.00
Market cap: ₹58,669 Cr
Revenue (annual): ₹16,927 Cr
Net profit (annual): ₹385.6 Cr
P/E (TTM): 118.5×Sector 47.4×
Promoter holding: 44.68%-0.23% QoQ
FII holding: 8.14%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Business Update 2 Regulatory Approval 1 Other Announcement 1 New Order Win 1 Earnings Call 1 Capital Structure Change 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

25 Aug 2026 08:28 IST NSE

Regulatory ApprovalAlfa Alert

Biocon Regulatory Approval

Biocon received marketing approval from Japan's MHLW for its Pegfilgrastim biosimilar. This approval enhances Biocon's biosimilar portfolio and market access in Japan.

Read the story on ALFA News Read the filing ↗